Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Biomedicines Année : 2022

Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders

Résumé

Pregnancy-associated disorders affect around 20% of pregnancies each year around the world. The risk associated with pregnancy therapeutic management categorizes pregnant women as “drug orphan” patients. In the last few decades, nanocarriers have demonstrated relevant properties for controlled drug delivery, which have been studied for pregnancy-associated disorders. To develop new drug dosage forms it is mandatory to have access to the right evaluation models to ensure their usage safety and efficacy. This review exposes the various placental-based models suitable for nanocarrier evaluation for pregnancy-associated therapies. We first review the current knowledge about nanocarriers as drug delivery systems and how placenta can be used as an evaluation model. Models are divided into three categories: in vivo, in vitro, and ex vivo placental models. We then examine the recent studies using those models to evaluate nanocarriers behavior towards the placental barrier and which information can be gathered from these results. Finally, we propose a flow chart on the usage and the combination of models regarding the nanocarriers and nanoparticles studied and the intended therapeutic strategy
Fichier principal
Vignette du fichier
Fliedel biomedicines-2022.pdf (2.79 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-03712174 , version 1 (02-07-2022)

Licence

Paternité

Identifiants

Citer

Louise Fliedel, Khair Alhareth, Nathalie Mignet, Thierry Fournier, Karine Andrieux. Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders. Biomedicines, 2022, 10 (5), pp.936. ⟨10.3390/biomedicines10050936⟩. ⟨hal-03712174⟩
59 Consultations
70 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More